Insomnia
Conditions
Interventions
This is a longitudinal, clinical trial-type, controlled and randomized study. In this context, a meditation program will be offered in the online environment for female participants, who present a cli
E02.190.525.374
Sponsors
Universidade Federal de São Paulo
Universidade Federal de São Paulo
Eligibility
Sex/Gender
Female
Age
18 Years to 47 Years
Inclusion criteria
Inclusion criteria: Women with insomnia; aged 18 to 47
Exclusion criteria
Exclusion criteria: Women who are already in the menopausal transition, that is, with an irregular menstrual cycle; women who declare that they have practiced some form of meditation and/or cognitive behavioral therapy for insomnia (CBT-I) in the last 2 months; women who have used medication for sleep and/or anxiety in the last month, such as: benzodiazepines, antihistamines, hypnotics, hypnotic herbal medicines, sedatives, antidepressants, antipsychotics, stimulants (amphetamine and modafinil) and corticosteroids; shift workers and illiterate participants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in the participants' insomnia severity, verified through responses to the IGI - Insomnia Severity Index and PSQI - Pittsburgh Sleep Quality Index questionnaires in pre- and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to see an improvement in the levels of anxiety, depression and quality of life, verified through the responses to the questionnaires Quality of life questionnaire developed by the World Health Organization (WHOQOL-Bref), Beck Depression Inventory (BDI), Beck Anxiety (BAI) | — |
Countries
Brazil
Contacts
Public ContactAndréia Bezerra
Universidade Federal de São Paulo
Outcome results
None listed